Inventor · Bagnols-sur-Cèze, FR

David Dukhan

25Patents
9h-index
27Co-inventors
71Inventor score

Filing activity: Nov 13, 2008 → Nov 24, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US9109001B2 3′,5′-cyclic phosphoramidate prodrugs for HCV infection Chemistry; Metallurgy 44 Active
US8362068B2 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors Chemistry; Metallurgy 44 Active
US8951985B2 Compounds and pharmaceutical compositions for the treatment of viral infections Human Necessities 31 Active
US9339541B2 Thiophosphate nucleosides for the treatment of HCV Emerging Cross-Sectional Technologies 25 Active
US8742101B2 Purine nucleoside analogues for treating flaviviridae including hepatitis C Chemistry; Metallurgy 23 Active
US8193372B2 Phosphothiophene and phosphothiazole HCV polymerase inhibitors Chemistry; Metallurgy 21 Active
US9296778B2 3′,5′-cyclic phosphate prodrugs for HCV infection Chemistry; Metallurgy 18 Active
US9309275B2 3′-deoxy nucleosides for the treatment of HCV Chemistry; Metallurgy 17 Active
US9403863B2 Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections Chemistry; Metallurgy 11 Active
US10519159B2 Antiviral aliphatic ester prodrugs of tenofovir Emerging Cross-Sectional Technologies 4 Active
US10030044B2 Nucleotides for the treatment of liver cancer Human Necessities 4 Active
US10449208B2 Antiviral prodrugs of tenofovir Human Necessities 3 Active
US10683321B2 4′-or nucleosides for the treatment of HCV Chemistry; Metallurgy 2 Active
US10815264B2 Nucleotides for the treatment of cancer Human Necessities 1 Active
US10899788B2 Cyclic phosphate substituted nucleoside compounds and methods of use thereof for the treatment of viral diseases Chemistry; Metallurgy 1 Active
US10202411B2 3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV Human Necessities 1 Active
US11730748B2 Cyclic phosphate substituted nucleoside derivatives for the treatment of liver diseases Chemistry; Metallurgy 0 Active
US10736908B2 Antiviral aryl-amide phosphodiamide compounds Chemistry; Metallurgy 0 Active
US10231986B2 Amino acid phosphoramidate pronucleotides of 2′-cyano, azido and amino nucleosides for the treatment of HCV Chemistry; Metallurgy 0 Active
US10238680B2 D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease Chemistry; Metallurgy 0 Active
US10005779B2 1′,4′-thio nucleosides for the treatment of HCV Chemistry; Metallurgy 0 Active
US9187496B2 5,5-fused arylene or heteroarylene hepatitis C virus inhibitors Chemistry; Metallurgy 0 Active
US10717758B2 D-amino acid compounds for liver disease Chemistry; Metallurgy 0 Active
US10766917B2 Nucleotides for the treatment of cancer Chemistry; Metallurgy 0 Active
US9186369B2 Purine nucleoside analogues for treating flaviviridae including hepatitis C Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.